Biocompatibles Archive

Biocompatibles Archive

  1. Form 8.3 - Biocompatibles International plc

  2. Rule 2.10 Announcement

  3. Eisai submits MAA in Japan for DC Bead

  4. Form 8.5 Biocompatibles International Plc

  5. Rule 2.10 Announcement

  6. Form 8.3 - Biocompatibles International plc

  7. Further re 2.11d Disclosure

  8. Form 8.5 Biocompatibles International Plc

  9. Form 8.3 - Biocompatibles International plc

  10. Further re 2.11d Disclosure

  11. Form 8.3 - Biocompatibles International plc

  12. Further re Rule 2.11d disclosure

  13. Form 8.3 - Biocompatibles International plc

  14. Further re Rule 2.11D

  15. Holding(s) in Company

  16. Form 8.5 - Biocompatibles International Plc

  17. Form 8 (DD) Biocompatibles International plc

  18. Form 8.3 - Biocompatibles Intl plc - Amendment

  19. Form 8.3 - Biocompatibles Intl plc

  20. Form 8.3 - Biocompatibles Intl plc

  21. Further re Rule 2.11d of Takeover Code

  22. Form 8 (DD) - BIOCOMPATIBLES INTERNATIONAL PLC

  23. Director/PDMR Shareholding

  24. Form 8 (DD) - Biocompatibles International plc

  25. Director/PDMR Shareholding

  26. Form 8.5 - Biocompatibles International Plc

  27. Form 8.3 - Biocompatibles Intl plc

  28. Director/PDMR Shareholding

  29. Acquisition of Biocompatibles

  30. Appointment of Corporate Broker

  31. Form 8 (DD) - Biocompatibles International plc

  32. Director/PDMR Shareholding

  33. UK and Australia study supports use of MoleMate

  34. Interim Management Statement

  35. Offer Update

  36. Form 8.3 - Biocompatibles International plc

  37. Form 8.5 (EPT/NON-RI)

  38. Form 8.5 (EPT/NON-RI)

  39. Form 8.3 - Biocompatibles International PLC

  40. Statement re Novabel Update

  41. Form 8.3 - Biocompatibles International PLC

  42. Form 8.5 (EPT/NON-RI)

  43. Form 8.5 (EPT/NON-RI)

  44. Form 8.5 (EPT/NON-RI)

  45. Form 8.5 (EPT/NON-RI)

  46. Form 8.5 (EPT/NON-RI)

  47. Form 8.3 - Biocompatibles International plc

  48. Blocklisting - Interim Review

  49. Form 8.5 (EPT/NON-RI)

  50. Form 8.3 - Biocompatibles International plc

  51. Form 8.5 (EPT/NON-RI)

  52. Form 8.3 - [Biocompatibles International Ltd]

  53. Form 8.5 (EPT/NON-RI)

  54. Blocklisting - Interim Review

  55. Director/PDMR Shareholding

  56. Form 8 (DD) - Biocompatibles International plc

  57. Form 8.5 (EPT/NON-RI)

  58. Form 8.5 (EPT/NON-RI)

  59. Director/PDMR Shareholding

  60. Form 8 (DD) - Biocompatibles International plc

  61. Form 8.5 (EPT/NON-RI)

  62. Form 8.5 (EPT/NON-RI)

  63. Director/PDMR Shareholding

  64. Form 8 (DD) - Biocompatibles International plc

  65. Form 8.5 (EPT/NON-RI)

  66. Form 8 (OPD) Biocompatibles International plc

  67. Director/PDMR Shareholding

  68. Form 8.5 (EPT/NON-RI)

  69. Form 8.3 - Biocompatibles International plc

  70. Form 8.5 (EPT/NON-RI)

  71. Holding(s) in Company

  72. First Patients treated in Type 2 Diabetes Programme

  73. Form 8.3 - Biocompatibles International plc

  74. Form 8.5 (EPT/NON-RI)

  75. Form 8.3 - Biocompatibles Intl Plc Ord GBP 0.21

  76. Form 8.3 - Biocompatibles International Plc

  77. Form 8.3 - Biocompatibles International plc

  78. Statement re Preliminary Approach

  79. Holding(s) in Company

  80. Director/PDMR Shareholding

  81. Director/PDMR Shareholding

  82. Half-yearly Report

  83. Statement re Clinical Trial

  84. Notice of Results

  85. Director/PDMR Shareholding

  86. Director/PDMR Shareholding

  87. REG-Biocompatibles Intl.: Statement re Patent Acquisition

  88. REG-Biocompatibles Intl.: Director/PDMR Shareholding

  89. REG-Biocompatibles Intl.: Statement re Novabel Product

  90. REG-Biocompatibles Intl.: Holding(s) in Company

  91. REG-Biocompatibles Intl.: Result of AGM

  92. REG-Biocompatibles Intl.: AGM Statement

  93. REG-Biocompatibles Intl.: Director/PDMR Shareholding

  94. REG-Biocompatibles Intl.: Director/PDMR Shareholding

  95. REG-Biocompatibles Intl.: Director/PDMR Shareholding

  96. REG-Biocompatibles Intl.: Interim Management Statement

  97. REG-Biocompatibles Intl.: Holding(s) in Company

  98. REG-Biocompatibles Intl.: Director/PDMR Shareholding

  99. REG-Biocompatibles Intl.: Annual Information Update

  100. REG-Biocompatibles Intl.: Publication of 2009 Annual Report and Notice of 2010 AGM

  101. Dividend Declaration

  102. Blocklisting - Interim Review

  103. Blocklisting - Interim Review

  104. Director/PDMR Shareholding

  105. Statement re EUR6.2m Grant

  106. Final Results - Part 1

  107. Final Results - Part 2

  108. Holding(s) in Company

  109. Director/PDMR Shareholding

  110. Research Update

  111. Total Voting Rights

  112. Additional Listing

  113. Director/PDMR Shareholding

  114. Director/PDMR Shareholding

  115. Trading Statement

  116. Director/PDMR Shareholding

  • Email alerts

    Stay up to date and register to receive the latest News and Press Releases by email.

    Email alerts RSS